Home Nucleus Pharmaceuticals China PCR-based Infectious Diseases Market to 2032

China PCR-based Infectious Diseases Market to 2032

Overview

The China PCR-based Infectious Diseases Market is expected to reach a 366.57 USD Million by 2032 and is projected to grow at a CAGR of 12.14% from 2025 to 2032.

Revenue, 2024 (USD Million)
176.96
Forecast, 2032 (USD Million)
366.57
CAGR, 2024 - 2032
12.14%
Report Coverage
China

China PCR-based Infectious Diseases Market 2018-2032 USD Million

China PCR-based Infectious Diseases Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 176.96 USD Million
  • Projected Market Size (2032): 366.57 USD Million
  • CAGR (2025-2032): 12.14%

Key Findings of China PCR-based Infectious Diseases Market

  • The China PCR-based Infectious Diseases Market was valued at 176.96 USD Million in 2024.
  • The China PCR-based Infectious Diseases Market is likely to grow at a CAGR of 12.14% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Laboratory Based Testing in Testing Segment accounted for the largest share of the market with a revenue of 110.52 USD Million
  • The fastest growing segment Tuberculosis PCR Test in Test Type Segment grew Fastest with a CAGR of 14.45% during the forecast period from 2024 to 2032.

China PCR-based Infectious Diseases Market Scope

China PCR-based Infectious Diseases Market Segmentation & Scope
Infection
  • Other Infections
  • Hospital Acquired Infections
  • Sexually Transmitted infection
  • Respiratory Tract Infection
  • Viral Infection
Pathogen
  • Others
  • Protozoa
  • Fungal
  • Bacterial
  • Viral
End User
  • Others
  • Home Healthcare
  • Academic And Research Institutes
  • Community Health Centers
  • Clinics
  • Hospital
  • Diagnostic Centers
Testing
  • Point of Care Testing
  • Laboratory Based Testing
Patient Type
  • Adults
  • Pediatric
  • Geriatric
PCR Technology
  • Others
  • Multiplex PCR
  • RT PCR
Test Type
  • Others PCR Test
  • Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
  • Mycoplasma Genitalium (Mg) PCR Test
  • Enterococcus PCR Test
  • Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
  • C.Difficile (Clostridium Difficile) PCR Test
  • Norovirus PCR Test
  • Sars (Covid-19) PCR Test
  • H. Pylori PCR Test
  • Bordetella PCR Test
  • Rotavirus PCR Test
  • Salmonellosis PCR Test
  • Gonorrhea PCR Test
  • Chlamydia Trachomatis Genital PCR Test
  • Human Papillomavirus (Hpv) PCR Test
  • Influenza PCR Test
  • Human Immunodeficiency Virus (Hiv) PCR Test
  • Hepatitis PCR Test
  • Tuberculosis PCR Test

China PCR-based Infectious Diseases Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 176.96 USD Million
Market Value in 2032 366.57 USD Million
CAGR (2025-2032) 12.14%
Historic Data 2016-2023
Market Segments Covered Infection,Pathogen,End User,Testing,Patient Type,PCR Technology,Test Type

Regional Insights:

  • Leading Market (2024-2032): China, leading in terms of revenue 176.96 USD Million in 2024
    • Key Country: China, leading in terms of revenue with value of 176.96 USD Million in 2024.

Segments and Scope

  • China PCR-based Infectious Diseases Market to 2032, By Infection
    • Viral Infection is the largest segment in China PCR-based Infectious Diseases Market to 2032 with a revenue of 77.23 USD Million in the year 2024.
    • Viral Infection is the Fastest growing segment in China PCR-based Infectious Diseases Market to 2032 with a Growth rate of 12.80 % in forecast period 2025-2032.
  • China PCR-based Infectious Diseases Market to 2032, By Pathogen
    • Viral is the largest segment in China PCR-based Infectious Diseases Market to 2032 with a revenue of 73.96 USD Million in the year 2024.
    • Viral is the Fastest growing segment in China PCR-based Infectious Diseases Market to 2032 with a Growth rate of 12.53 % in forecast period 2025-2032.
  • China PCR-based Infectious Diseases Market to 2032, By End User
    • Diagnostic Centers is the largest segment in China PCR-based Infectious Diseases Market to 2032 with a revenue of 48.44 USD Million in the year 2024.
    • Diagnostic Centers is the Fastest growing segment in China PCR-based Infectious Diseases Market to 2032 with a Growth rate of 13.88 % in forecast period 2025-2032.
  • China PCR-based Infectious Diseases Market to 2032, By Testing
    • Laboratory Based Testing is the largest segment in China PCR-based Infectious Diseases Market to 2032 with a revenue of 110.52 USD Million in the year 2024.
    • Laboratory Based Testing is the Fastest growing segment in China PCR-based Infectious Diseases Market to 2032 with a Growth rate of 12.42 % in forecast period 2025-2032.
  • China PCR-based Infectious Diseases Market to 2032, By Patient Type
    • Geriatric is the largest segment in China PCR-based Infectious Diseases Market to 2032 with a revenue of 74.44 USD Million in the year 2024.
    • Geriatric is the Fastest growing segment in China PCR-based Infectious Diseases Market to 2032 with a Growth rate of 12.94 % in forecast period 2025-2032.
  • China PCR-based Infectious Diseases Market to 2032, By PCR Technology
    • RT PCR is the largest segment in China PCR-based Infectious Diseases Market to 2032 with a revenue of 76.49 USD Million in the year 2024.
    • RT PCR is the Fastest growing segment in China PCR-based Infectious Diseases Market to 2032 with a Growth rate of 12.96 % in forecast period 2025-2032.
  • China PCR-based Infectious Diseases Market to 2032, By Test Type
    • Tuberculosis PCR Test is the largest segment in China PCR-based Infectious Diseases Market to 2032 with a revenue of 24.49 USD Million in the year 2024.
    • Tuberculosis PCR Test is the Fastest growing segment in China PCR-based Infectious Diseases Market to 2032 with a Growth rate of 14.45 % in forecast period 2025-2032.

China PCR-based Infectious Diseases Market Company Share Analysis

 
China PCR-based Infectious Diseases Market Company Share Analysis
China PCR-based Infectious Diseases Market Company Share Analysis

China PCR-based Infectious Diseases Market Geographical Sales Distribution, 2018-2032 USD Million

China PCR-based Infectious Diseases Market Geographical Sales Distribution, 2018-2032 USD Million

China PCR-based Infectious Diseases Market Company Profiling

China PCR-based Infectious Diseases Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The China PCR-based Infectious Diseases Market is segmented based on Segmentation Infection,Pathogen,End User,Testing,Patient Type,PCR Technology,Test Type.
China PCR-based Infectious Diseases Market was valued at USD 176.96(Revenue in USD Million) in 2022.
China PCR-based Infectious Diseases Market is projected to grow at a CAGR of 12.14% during the forecast period of 2024 to 2032.
The Laboratory Based Testing segment is expected to dominate the China PCR-based Infectious Diseases Market, holding a largest market share of 110.52 USD Million in 2024

China PCR-based Infectious Diseases Market Scope

China PCR-based Infectious Diseases Market Segmentation & Scope
Infection
  • Other Infections
  • Hospital Acquired Infections
  • Sexually Transmitted infection
  • Respiratory Tract Infection
  • Viral Infection
Pathogen
  • Others
  • Protozoa
  • Fungal
  • Bacterial
  • Viral
End User
  • Others
  • Home Healthcare
  • Academic And Research Institutes
  • Community Health Centers
  • Clinics
  • Hospital
  • Diagnostic Centers
Testing
  • Point of Care Testing
  • Laboratory Based Testing
Patient Type
  • Adults
  • Pediatric
  • Geriatric
PCR Technology
  • Others
  • Multiplex PCR
  • RT PCR
Test Type
  • Others PCR Test
  • Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
  • Mycoplasma Genitalium (Mg) PCR Test
  • Enterococcus PCR Test
  • Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
  • C.Difficile (Clostridium Difficile) PCR Test
  • Norovirus PCR Test
  • Sars (Covid-19) PCR Test
  • H. Pylori PCR Test
  • Bordetella PCR Test
  • Rotavirus PCR Test
  • Salmonellosis PCR Test
  • Gonorrhea PCR Test
  • Chlamydia Trachomatis Genital PCR Test
  • Human Papillomavirus (Hpv) PCR Test
  • Influenza PCR Test
  • Human Immunodeficiency Virus (Hiv) PCR Test
  • Hepatitis PCR Test
  • Tuberculosis PCR Test
Frequently Asked Questions
The China PCR-based Infectious Diseases Market is segmented based on Segmentation Infection,Pathogen,End User,Testing,Patient Type,PCR Technology,Test Type.
China PCR-based Infectious Diseases Market was valued at USD 176.96(Revenue in USD Million) in 2022.
China PCR-based Infectious Diseases Market is projected to grow at a CAGR of 12.14% during the forecast period of 2024 to 2032.
The estimated market value of the China PCR-based Infectious Diseases Market for final year is USD 366.57 (USD Million).

China PCR-based Infectious Diseases Market Company Profiling

China PCR-based Infectious Diseases Market Company Profiling
Frequently Asked Questions
The China PCR-based Infectious Diseases Market is segmented based on Segmentation Infection,Pathogen,End User,Testing,Patient Type,PCR Technology,Test Type.
China PCR-based Infectious Diseases Market was valued at USD 176.96(Revenue in USD Million) in 2022.
China PCR-based Infectious Diseases Market is projected to grow at a CAGR of 12.14% during the forecast period of 2024 to 2032.
The estimated market value of the China PCR-based Infectious Diseases Market for final year is USD 366.57 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES